Articles tagged with Pharmacology
A clinical trial aims to evaluate whether laser therapy reduces vaginal dryness caused by breast cancer treatment. The study, REVITALIZE, plans to enroll approximately 250 women with a history of breast cancer who experience moderate to severe vaginal dryness.
Researchers found that squalene-based adjuvants activate distinct pathways for vaccine protection and reactogenicity, including the role of IL-1β in enhancing efficacy and IL-1α in triggering local swelling. The study's findings could lead to safer vaccine design by targeting specific immune mechanisms.
Scientists at the University of Kent have found that madecassic acid inhibits the ability of antibiotic-resistant E. coli to grow, suggesting it could serve as an alternative antimicrobial. The study shows three modified variants of the compound effectively inhibited cytochrome bd and shut down bacterial growth.
Scientists at NTU Singapore found that glycerol-3-phosphate acyltransferase (GPAT) amplifies α-synuclein toxicity by altering fat metabolism in brain cells. Targeting GPAT activity may offer a new strategy for treating Parkinson's disease.
Researchers discovered that neuronal nitric oxide synthase drives neuroblastoma through the mTOR signaling cascade. Treating cancer cells with a selective inhibitor called BA-101 collapsed tumor growth in mice with striking force, and silencing the nNOS gene also led to significant results.
In this randomized clinical trial, mirtazapine effectively reduced methamphetamine use in adults with methamphetamine use disorder. The study's findings have important implications for the treatment of this condition, which currently lacks approved pharmacotherapies.
A hormone called FGF21 reverses obesity in mice by signaling to the hindbrain, a region targeted by GLP-1 drugs. This finding provides insight into the naturally occurring hormone's benefits for weight loss and MASH treatment.
Scientists have discovered genetic pathways and compounds that protect cone photoreceptors, crucial for central vision, from degeneration associated with age-related macular degeneration. The study used human retinal organoids and identified two kinase inhibitors as key protective mechanisms.
Researchers discovered that even tiny amounts of PFDA cause visible facial changes and increase risk by 10% at low exposure levels. PFDA blocks key enzyme CYP26A1, disrupting retinoic acid metabolism and leading to abnormal facial development.
A study reveals dermcidin, a human body natural molecule, exhibits antiviral activity against the influenza virus. Higher baseline levels of dermcidin in individuals who don't develop flu-like symptoms may be associated with lower susceptibility to infection.
A new approach allows oral delivery of drugs previously requiring injection by piggybacking on natural fat absorption pathways. The medication, GlyphAllo, bypasses the liver's security checkpoint and is absorbed through the gut's lymphatic system, allowing it to enter the bloodstream directly.
A team of researchers has developed a novel 3D atlas technology, enabling comprehensive understanding of cell distribution across entire organs or the whole organism. This innovation combines with existing gene expression data to advance disease understanding and create new indicators.
Researchers have developed a low-cost fake drug detector that uses an infrared sensor to track pill dissolution rates. The device can identify legitimate medications from counterfeit ones with high accuracy, making it a valuable tool in the fight against global health threats.
Researchers have discovered how a light-switchable beta blocker interacts with its biological receptor, allowing for targeted treatment of high blood pressure. The new compound's shape changes in response to light, reducing its potency and minimizing side effects.
Dr. Gobbi challenges the global drug-development system, stating that promising treatments for mental illness are failing to reach patients due to venture capital and profit motives. Her research focuses on cannabis, melatonin, and psychedelics, with a goal of improving public-health decisions and treatment outcomes.
Researchers engineered Escherichia coli Nissle 1917 bacteria to produce anticancer agent Romidepsin, which was released from the bacteria and effectively targeted cancer cells in mouse models. The study establishes a solid foundation for bacteria-assisted tumor-targeted therapy, paving the way for future advancements in cancer treatment.
A new clinical trial will investigate whether adding the oral medication vorasidenib to standard chemotherapy improves progression-free survival for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma. The study aims to recruit 400 individuals with this type of brain cancer and evaluate the safety and side-effect profile of the...
Researchers at the University of Edinburgh have developed a method to transform post-consumer plastic into L-DOPA, a frontline medication for Parkinson's disease. The process harnesses the power of bacteria to break down PET waste and produce L-DOPA, providing a sustainable solution to the production of pharmaceuticals.
Scientists have discovered that mosquitoes use a specific sensory receptor to detect and avoid borneol, an organic compound found in plant-based mosquito repellents. This finding has the potential to lead to the development of more effective and longer-lasting repellents.
Researchers developed GluBs to target ASCT2 in aggressive cancers, bypassing the LAT1 route. The agents showed efficacy in limiting tumor growth and demonstrating potential to treat cancers with limited LAT1 expression.
Researchers evaluated 12 hypnotic medications on sleep architecture and respiratory function in adults with obstructive sleep apnea. The study found that while some medications worsened respiratory outcomes, others showed no significant effects, highlighting the need for individualized treatment.
Scientists identify Roseburia genus bacteria in human intestine associated with increased muscle mass and strength. The study suggests that the bacteria could be used as a probiotic to help preserve muscle strength during aging.
Jeonbuk National University researchers have developed DDINet, a lightweight and scalable model that can accurately predict drug-drug interactions for new, unseen drugs. This approach avoids overfitting to training data and is designed to handle binary and multi-classification tasks.
Researchers discovered yaku'amide B induces CD9 degradation, a cancer stem cell-related protein, in addition to inhibiting ATP synthase, leading to cellular energy depletion and cancer cell suppression. This natural compound has potential as a new therapeutic approach for cancer treatment.
The latest issue of Current Pharmaceutical Analysis features advanced analytical characterization and emerging trends in pharmaceutical science. Open access articles can be freely viewed and downloaded on ScienceDirect.
Researchers at Hokkaido University developed a new platform to evaluate male reproductive function in living mice, enabling non-invasive, real-time monitoring of fertility. This approach reduces animal use and costs, while providing continuous and long-term data, and has potential applications in oncofertility research.
Researchers at ETH Zurich have developed a new boron-based coupling method that enables the rapid production of key proteins for cancer therapies, overcoming the concentration barrier in chemical protein synthesis. This breakthrough allows for the creation of new peptide and protein medications, as well as unnatural amino acids with sp...
Research shows that bacteria harbor resistance genes may respond differently to antibiotics under non-standard conditions. This affects treatment efficacy and contributes to understanding antimicrobial resistance development and spread. Understanding these variations is crucial to combat global public health threats.
A low-cost digital intervention increased expectation to adopt health behaviors among adults using GLP-1RAs, with effects persisting for 2 weeks. The written microsteps intervention plus short video boosters may play a role in promoting sustained behavior change.
The Alliance for Clinical Trials in Oncology is spotlighting new trials for colorectal cancer in March, focusing on early detection methods and treatments for treatment delays and loss of appetite. The trials aim to improve patient outcomes, with several enrolling patients with newly diagnosed colon or rectal cancer.
Researchers at Goethe University are developing non-hormonal contraceptives to address declining pill use and side effects. The PREVENT project aims to create safe and effective alternatives, focusing on small molecules that block proteins in sperm or egg cells.
A large cohort study found that people using anticholinergic medications, commonly prescribed for urinary incontinence and anxiety, have a higher risk of developing cardiovascular disease. The cumulative use of these drugs was associated with an increased risk of heart failure and arrhythmias.
A University of Sydney-led study found that honey made from mixed floral sources has superior performance against bacteria, with high levels of bioactive compounds. The findings could help develop new treatments for drug-resistant infections while supporting bushfire recovery and sustainable beekeeping practices.
A recent study by Mizzou researchers found that some young adults with autism exhibit abnormalities in dopamine transporters on brain scans, which could be early biomarkers for potential Parkinson's disease development. This discovery may help identify individuals at greater risk and inform preventative measures.
Researchers found Xijiaqi Formula reduces neuroinflammation and promotes neuroplasticity in CHF rats, improving cognitive function. The formula also enhances molecular signatures of neuroplasticity by regulating PDE4-cAMP/PKA/CREB signaling.
Researchers have found that remote ischemic conditioning can protect the heart without reducing antitumor efficacy in cancer patients undergoing anthracycline treatment. This non-pharmacological technique may reduce long-term cardiovascular complications and improve quality of life.
Researchers at Arizona State University uncovered a scientific principle governing how nanoparticles interact with water in the body, leading to improved drug delivery. The study measured hydration energetics on biomolecule-coated magnetite nanoparticles, revealing altered interactions, immune recognition, and circulation potential.
A novel delivery method using microscopic lipid bubbles has successfully delivered a neuroprotective molecule to the brain, improving motor function in mice with ALS. The breakthrough could pave the way for human clinical trials to slow down or halt disease progression.
The Alliance for Clinical Trials in Oncology will host a webinar highlighting recent clinical advances in breast cancer, multiple myeloma, and leukemia. Researchers will present key findings from ASH and SABCS meetings, impacting treatment outcomes.
Researchers have identified new microbial species in corals that produce unique natural products, offering a vast arsenal of potential benefits to humanity. The study highlights the importance of protecting coral reefs' microbiomes to tap into this untapped resource before it's lost forever.
The study found that opioids provide only small, time-limited pain relief for certain pain conditions, such as stomach pain and dental surgery. Regular use of opioids comes with a risk of harm, including dependence and overdose.
Alpha-gal syndrome is a growing concern in Missouri and beyond, causing delayed symptoms such as hives, stomach pain, and severe throat swelling. Mizzou researchers and MU Extension are working together to educate the public about alpha-gal syndrome and provide resources for those affected.
Researchers at the University of Gothenburg have found that tirzepatide, the active ingredient in Mounjaro, reduces voluntary alcohol consumption by more than half in animals. The study also shows that the drug prevents relapse-like drinking and decreases drinking levels after a period without alcohol.
Researchers developed a free-to-use software tool, PSBench, to verify the accuracy of artificial intelligence-based protein structure predictions. The database includes 1.4 million annotated protein models, verified by experts, and provides reliable information for building more accurate AI systems.
The study identifies SRJ09 as a top candidate for treating beta thalassemia due to its favorable binding affinity to the active site of histone deacetylase 2 (HDAC2). The compound exhibited acceptable drug-likeness properties and stable complex behavior with HDAC2.
Researchers are developing a new compound that can break down MDM2, a cancer-driving protein often found in triple-negative breast cancer, showing promise in shrinking tumors. The goal is to create an entirely new class of therapies for this aggressive and difficult-to-treat form of the disease.
MIT researchers used a large language model to optimize the genetic sequences of proteins manufactured by yeast, reducing production costs. The new model predicted which codons would work best for manufacturing six different proteins, including human growth hormone and a monoclonal antibody, with successful results.
Researchers developed antibody–drug conjugates that combine CD4 mimic and neutralizing antibodies to target HIV entry, showing seven times better efficacy than existing approaches. The strategy aims to block HIV before it enters the host cell, offering a more targeted therapeutic profile and potentially reducing adverse effects.
The study investigated the bioactive polyphenolic compounds and their anti-degenerative properties in foliar tissues of Amaranthus hypochondriacus L. The results showed germplasm-specific variations in pharmacological potential, with some accessions exhibiting promising anti-degenerative properties.
Research shows that psychedelics suppress visual processing by activating the 2A receptor, leading to hallucinations as the brain fills the gap with fragmented memories. Short-term oscillations also play a crucial role in communication between brain areas.
Researchers investigated the binding thermodynamics of doxepin geometric isomers to the histamine H1 receptor, revealing differences in enthalpy and entropy contributions. The study highlights the importance of considering conformational constraints in designing ligands with optimized thermodynamic properties.
Matthew J. Robson, PhD, a University of Cincinnati associate professor, received the 2026 Neuropharmacology Early Career Award for his research on serotonin neurotransmission and its impact on traumatic brain injury. The award honors young independent investigators in neuropharmacology.
Researchers at NTU Singapore develop a new orally taken, gut-based compound that reduces dietary fat absorption in the intestines. The technology supports weight loss while minimizing effects on other organs and reducing stress on the liver when dietary fat intake is high.
A new Cochrane review found that nurse-led hospital care matches doctor-led care for safety and effectiveness, but may achieve better outcomes in some areas. Nurse substitution is not a one-size-fits-all approach, requiring the right training and support to work well.
A new national survey found that nearly three-quarters of clinicians encounter obstacles when starting buprenorphine treatment for patients using fentanyl. Researchers emphasize the need for evidence-based guidelines to initiate buprenorphine in light of more potent drugs.
Scientists have successfully grown human norovirus in the lab for up to 15 consecutive passages, enabling comprehensive studies of viral structure, antiviral drug screening, and vaccine development. The breakthrough uses a drug called TAK 779 to overcome host restrictions, allowing researchers to produce stable virus stocks.
Researchers have designed antibodies that recognize a unique sugar found on bacterial cells, providing a potential new treatment for multidrug-resistant hospital-acquired infections. The target of the antibody is pseudaminic acid, a sugar molecule produced exclusively by bacteria and used to evade immune responses.
Researchers discovered that ATG triggers rapid clotting and inflammation in the liver by activating a complement activation system and TGF-β pathway, leading to severe side effects. The study used human organoid models and imaging analysis to reveal the biphasic mechanism of ATG-induced liver injury.
A team of researchers has discovered an oral compound that selectively induces the mammalian clock gene Per1, promoting a dual E-box DNA element's activation. This results in the advancement of both central and peripheral clocks, advancing jet lag and shift work-related sleep disorders.
The MIT research team has designed a new type of tissue model that accurately replicates the physiology of the liver, including blood vessels and immune cells. The model was used to study metabolic dysfunction-associated steatotic liver disease (MASLD) and showed promising results in identifying potential treatments.